6190-39-2
Dihydroergotamine Mesylate
CAS: 6190-39-2
Molecular Formula: C34H41N5O8S
6190-39-2 - Names and Identifiers
| Name | Dihydroergotamine Mesylate |
| Synonyms | Agit D.H.E. 45 Angionorm Dergotamine Dihydroergotamine Mesylate 9,10-dihydroergotaminemesylate dihydroergotamine methanesulfonate 9,10-dihydro-ergotaminmonomethanesulfonate(salt) 5'-Benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman 9,10-Dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trionemonomethanesulfonate (5'alpha)-5'-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman methanesulfonate (salt) (2'ξ,5'α,12'ξ)-5'-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman methanesulfonate (salt) |
| CAS | 6190-39-2 |
| EINECS | 228-235-6 |
| InChI | InChI=1/C33H37N5O5.CH4O3S/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32;1-5(2,3)4/h3-6,8-11,17,21,23,25-27,34,42H,7,12-16,18H2,1-2H3,(H,35,39);1H3,(H,2,3,4)/t21-,23?,25-,26+,27+,32?,33?;/m1./s1 |
6190-39-2 - Physico-chemical Properties
| Molecular Formula | C34H41N5O8S |
| Molar Mass | 679.78 |
| Melting Point | 232°C |
| Boling Point | 1001.8°C at 760 mmHg |
| Flash Point | 559.7°C |
| Solubility | methanol: 21mg/mL |
| Vapor Presure | 0mmHg at 25°C |
| Appearance | powder |
| Color | white |
| Merck | 14,3174 |
| Storage Condition | Store at RT |
| Stability | Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 2 months. |
| Refractive Index | -20 ° (C=0.25, JP Me |
6190-39-2 - Risk and Safety
| Hazard Symbols | Xn - Harmful |
| Risk Codes | 20/21/22 - Harmful by inhalation, in contact with skin and if swallowed. |
| Safety Description | 36 - Wear suitable protective clothing. |
| UN IDs | 1544 |
| WGK Germany | 3 |
| RTECS | KE7920000 |
| HS Code | 2939690000 |
| Hazard Class | 6.1(b) |
| Packing Group | III |
6190-39-2 - Introduction
Nature:
1. It is a white crystalline solid that is often soluble in water and alcohol solvents.
2. Stable at room temperature, with good stability to light and heat.
Method:
Usually, it is necessary to react dihydroergotamine with methanesulfonic acid to form a salt form under appropriate conditions. The preparation process requires strict control of reaction conditions and purity to ensure product quality.
Security information:
1. During use, there may be some adverse reactions such as dizziness, nausea, vomiting, etc.
2. Do not exceed the recommended dosage to avoid more serious side effects.
3. Patients with cardiovascular diseases, hypertension, and other conditions should consult a doctor before use.
4. Pregnant and lactating women should use it with caution under the guidance of a doctor.
Last Update：2024-05-21 11:38:05
